How much does Ultibro Breezhaler (Indacaterol Maleate and Glycopyrronium Bromide Powder for Inhalation) Cost& price without insurance in China?
Ultibro Breezhaler® is the commercial brand name of Indacaterol Maleate and Glycopyrronium Bromide Powder for Inhalation, a fixed‑dose combination inhaled bronchodilator developed by Novartis. Indacaterol maleate is a long‑acting β₂ agonist while glycopyrronium bromide is a long‑acting muscarinic antagonist; the two components work together to relax airway smooth muscle, dilate bronchi and improve pulmonary ventilation.
Main Indications
Long‑term maintenance therapy for airflow limitation in adult patients with chronic obstructive pulmonary disease (COPD).
Common Side Effects
Common mild adverse reactions: Dry mouth, nasopharyngitis, headache, cough, joint pain and throat irritation.
Laboratory abnormalities: Rare slight electrolyte disturbance.
Severe but manageable risks: Tachycardia, anaphylactic reactions and paradoxical bronchospasm.
Approval Status in China
Ultibro Breezhaler® (specification:110μg/50μg, domestic Chinese brand name: Jierun) was officially approved for marketing in China in 2015. It is currently a prescription drug included in China’s Category B medical insurance.
Buy Ultibro Breezhaler (Indacaterol Maleate and Glycopyrronium Bromide Powder for Inhalation) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
